Kyowa Kirin Revenue and Competitors
Estimated Revenue & Valuation
- Kyowa Kirin's estimated annual revenue is currently $164M per year.
- Kyowa Kirin's estimated revenue per employee is $201,000
Employee Data
- Kyowa Kirin has 816 Employees.
- Kyowa Kirin grew their employee count by -12% last year.
Kyowa Kirin's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Head Global Audit and R&D Quality | Reveal Email/Phone |
2 | VP, Head Digital | Reveal Email/Phone |
3 | SVP General Counsel & Chief Compliance Officer | Reveal Email/Phone |
4 | Head Digital EMBU | Reveal Email/Phone |
5 | Head Legal (Interim) | Reveal Email/Phone |
6 | Head Warehousing and Distribution | Reveal Email/Phone |
7 | Head Tax, EMEA Region | Reveal Email/Phone |
8 | Head Regulatory Affairs EMEA and Global Head RA Strategy | Reveal Email/Phone |
9 | Head Pharmaceutical Science | Reveal Email/Phone |
10 | SVP, Head Corporate Affairs, Member Executive Committee | Reveal Email/Phone |
Kyowa Kirin Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Kyowa Kirin?
As an agent for Kyowa Hakko Kirin (KHK), KKC is continuously searching for novel technologies and pharmaceutical products which represent licensing and/or partnering opportunities attractive to KHK's business platforms. KKC is interested in products and technologies that have been developed in both academic and industrial sectors. For potential in-licensing to KHK, KKC is looking for product candidates at any stage of development in the following core disease areas: Oncology, renal diseases, immune disorders and allergy. KKC also seeks partners who have novel technologies that can facilitate KHK's R&D efforts in the following fields
keywords:N/AN/A
Total Funding
816
Number of Employees
$164M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kyowa Kirin News
Kyowa Kirin Co. Ltd., Pfizer Inc., Astellas Pharma, Bayer AG, Elorac Dover Medical and Scientific Equipment, Ltd.
Kyowa Kirin is finalizing its Phase 3 clinical program for tenapanor for hyperphosphatemia and has disclosed its current expectation to file for...
Ardelyx and its Japanese collaboration partner Kyowa Kirin have amended their license agreement for tenapanor. contract-g78195e06a_1280.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $197M | 843 | -1% | $482.8M |
#2 | $304.5M | 870 | 5% | N/A |
#3 | $276.9M | 899 | N/A | N/A |
#4 | $200M | 985 | 9% | N/A |
#5 | $180.9M | 994 | N/A | N/A |